Medicamen Organics Limited (NSEI: MEDIORG)
Health Care · Pharmaceuticals · IN
Rs23.35
-4.89% today · -33.2% 1Y
Medicamen Organics Limited (NSEI: MEDIORG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.94M and employs 114 people.
Over the last twelve months the share price has lost 33.2%, trading between 19.10 and 38.00.
Tweenvest scores Medicamen Organics Limited across four factors: quality 56/100, value 38/100, growth 0/100. Its strongest factor is quality.
MEDIORG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.94M
- Revenue (TTM)
- $2.42M
- P/E
- —
- EPS
- -3.41
- Dividend yield
- —
- Beta (5Y)
- 1.31
- 52-week high
- Rs38.00
- 52-week low
- Rs19.10
- Avg volume (3M)
- —
- Shares outstanding
- 12.17M
- Employees
- 114
- Next earnings
- —
About Medicamen Organics Limited
Medicamen Organics Ltd. is engaged in developing, manufacturing and distribution of pharmaceutical dosage form such as tablets, capsules, oral liquids and ointments. The company was founded on March 15, 1995 and is headquartered in New Delhi, India.
- ISIN
- INE0PE401018
- Founded
- 1995
- Listed since
- Jun 28, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PRF Technologies Ltd.NasdaqCM: PRFX | $3.08M | $0.88 | -4.47% |
| Grey Matters Health Inc.CNSX: GREY | $3.05M | CA$0.39 | +1.32% |
| Emmaus Life Sciences, Inc.OTCPK: EMMA | $3.00M | $0.04 | +1.42% |
| Nextleaf Solutions Ltd.CNSX: OILS | $2.98M | CA$0.03 | -16.67% |
| Nextgen Biomed LtdTASE: NXGN-M | $2.93M | ₪— | — |
| Gujarat Terce Laboratories LimitedBSE: 524314 | $2.91M | Rs36.20 | +2.96% |
| Invion LimitedASX: IVX | $2.90M | AU$0.04 | -2.56% |
| Noveris Health Sciences Inc.CNSX: NVRS | $2.87M | CA$0.07 | -12.50% |
Figures last refreshed Oct 11, 2026.